Patenting Strategies of the EU Pharmaceutical Industry: Regular Business Practice or Abuse of Dominance
World Competition · 2012-03-01 · 35 (Issue 1) · 27-54
DOI: 10.54648/woco2012003 ↗At a glance
Journal article in World Competition, published on 2012-03-01. Written by Nicoleta Tuominen. Cited 3 times so far (Crossref).
Abstract (original language)
The aim of the present article is to offer a critical and objective view on the use or abuse of patents and defensive strategies in the pharmaceutical industry. It shall also seek to establish whether patents as currently regulated offer an appropriate degree of protection of intellectual property (IP) held by the economic operators in the pharmaceutical sector and whether there is a need or, for that matter, scope for improvement.
Cite
APA
Tuominen, N. (2012). Patenting Strategies of the EU Pharmaceutical Industry: Regular Business Practice or Abuse of Dominance. World Competition, 35(Issue 1), 27-54. https://doi.org/10.54648/woco2012003
Vancouver
Tuominen N. Patenting Strategies of the EU Pharmaceutical Industry: Regular Business Practice or Abuse of Dominance. World Competition. 2012;35(Issue 1):27-54. doi:10.54648/woco2012003
BibTeX
@article{Tuominen2012,
author = {Tuominen, Nicoleta},
title = {Patenting Strategies of the EU Pharmaceutical Industry: Regular Business Practice or Abuse of Dominance},
journal = {World Competition},
year = {2012},
volume = {35},
number = {Issue 1},
pages = {27--54},
doi = {10.54648/woco2012003}
}
EUVIMED